Fragment, CJC-1295 (no DAC), and Ipamorelin is a research peptide blend combining hGH Fragment 176–191 with GHRH and ghrelin receptor agonists for coordinated growth hormone axis modeling. The fragment modulates AMPK and β-adrenergic signaling, CJC-1295 (Mod GRF 1–29) activates GHRH receptor pathways, and Ipamorelin stimulates calcium-dependent GHS-R1a signaling. This blend supports research into metabolic peptide synergy and hypothalamic–pituitary function.
For research use only. Not for human consumption.
References:
Ng FM et al., Metabolism, 2002 51(12):1739–1743
Teichman SL et al., J Clin Endocrinol Metab, 2006 91(2):479–487
Kojima M et al., Nature, 1999 402(6762):656–660
Fragment, CJC-1295 (no DAC), Ipamorelin 12mg (Blend)
$100.00
Fragment, CJC-1295 (no DAC), and Ipamorelin is a research peptide blend combining hGH Fragment 176–191 with GHRH and ghrelin receptor agonists for coordinated growth hormone axis modeling. The fragment modulates AMPK and β-adrenergic signaling, CJC-1295 (Mod GRF 1–29) activates GHRH receptor pathways, and Ipamorelin stimulates calcium-dependent GHS-R1a signaling. This blend supports research into metabolic peptide synergy and hypothalamic–pituitary function.
Description
Shipping & Delivery
Related products
Dihexa (5mg x 60 Capsules = 300mg)
Dihexa is a small peptide-derived compound designed to support cognitive function and brain regeneration. It acts by activating the HGF/c-Met signaling pathway, which plays a critical role in forming new synaptic connections and enhancing neuroplasticity. Dihexa also mimics the action of brain-derived neurotrophic factor (BDNF), a key molecule involved in learning, memory, and neuronal survival. Preclinical research studies have shown that Dihexa can significantly improve memory consolidation and reverse cognitive deficits in models of Alzheimer’s disease, traumatic brain injury, and stroke. Unlike traditional nootropics or growth factors with poor blood–brain barrier penetration, Dihexa is orally bioavailable and metabolically stable, allowing for targeted CNS effects. Its unique mechanism positions it as a promising research compound for neurodegenerative conditions, offering potential in synaptic repair, inflammation reduction, and long-term cognitive enhancement. 
Melanotan 2 (MT2) (3mg x 10 Vials = 30mg)
Melanotan-2 (MT-2) is a synthetic derivative of human alpha-melanocyte-stimulating hormone (α-MSH), developed at the University of Arizona in the 1980s. The initial purpose was to create a sunless tanning alternative, inspired by α-MSH's ability to induce sexual arousal and skin darkening in rodents. However, as research progressed, MT-2's diverse effects were unveiled. These include enhancing sexual arousal, promoting skin pigmentation, reducing compulsive behavior, managing addiction, suppressing hunger, decreasing glucagon production, and even potentially reversing certain features associated with autism. Melanotan-2 research has shown it to enhance sexual arousal, promote skin pigmentation through melanocyte activation and reduce compulsive/addictive behaviors.
Semaglutide 10
Semaglutide is a widely researched peptide-based compound recognized for its significant role in metabolic regulation and appetite control. It belongs to the class of GLP-1 receptor agonists, which are designed to mimic naturally occurring hormones involved in glucose metabolism and satiety signaling.
TB-500 (Thymosin Beta-4) (43aa) (2mg x 10 Vials = 20mg)
TB-500 (Thymosin Beta-4) is a 43 amino acid peptide sequence. In animal models, Thymosin Beta-4 has been shown to improve blood vessel growth, regulate wound healing, decrease inflammation, and reduce oxidative damage in the heart and central nervous system. Thymosin-beta-4 has a role in protection, tissue repair, regeneration and remodeling of injured or damaged tissues. It is also of active interest in anti-aging research.
Reviews
There are no reviews yet.